LOS ANGELES--(BUSINESS WIRE)--Abraxis BioScience, Inc. (NASDAQ:ABII), a fully integrated, global biotechnology company, today announced that in connection with its strategic plan to spin-off Abraxis Health, it has named Lex H.T. Van der Ploeg, Ph.D., as Senior Vice President of Integrative Medicine and Translational Science. Abraxis Health will be dedicated to becoming a next-generation, evidence-based, personalized healthcare company.
